Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®

NCT04855799 is registered in ClinicalTrials.gov with James Varani as lead sponsor.

NCT NCT04855799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®
Lead sponsor
James Varani
Phase
Phase 2
Overall status
Completed
Start date
November 2, 2021
Completion date
March 25, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, irritable bowel syndrome with diarrhea, ulcerative colitis